These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New strategies for the treatment of lysosomal storage diseases (review). Parenti G; Pignata C; Vajro P; Salerno M Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354 [TBL] [Abstract][Full Text] [Related]
4. Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications. Biffi A Mol Ther; 2017 May; 25(5):1155-1162. PubMed ID: 28389320 [TBL] [Abstract][Full Text] [Related]
5. Treatment strategies for lysosomal storage disorders. Beck M Dev Med Child Neurol; 2018 Jan; 60(1):13-18. PubMed ID: 29090451 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy of storage disorders by retroviral and lentiviral vectors. Biffi A; Naldini L Hum Gene Ther; 2005 Oct; 16(10):1133-42. PubMed ID: 16218774 [No Abstract] [Full Text] [Related]
7. Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges. Köse S; Aerts-Kaya F; Uçkan Çetinkaya D; Korkusuz P Adv Exp Med Biol; 2021; 1347():135-162. PubMed ID: 33977438 [TBL] [Abstract][Full Text] [Related]
8. Cell and gene-based therapies for the lysosomal storage diseases. Hodges BL; Cheng SH Curr Gene Ther; 2006 Apr; 6(2):227-41. PubMed ID: 16611044 [TBL] [Abstract][Full Text] [Related]
9. Lysosomal storage diseases: from pathophysiology to therapy. Parenti G; Andria G; Ballabio A Annu Rev Med; 2015; 66():471-86. PubMed ID: 25587658 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy for the neurological manifestations in lysosomal storage disorders. Cheng SH J Lipid Res; 2014 Sep; 55(9):1827-38. PubMed ID: 24683200 [TBL] [Abstract][Full Text] [Related]
11. Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development. Massaro G; Geard AF; Liu W; Coombe-Tennant O; Waddington SN; Baruteau J; Gissen P; Rahim AA Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33924076 [TBL] [Abstract][Full Text] [Related]
12. An update on gene therapy for lysosomal storage disorders. Nagree MS; Scalia S; McKillop WM; Medin JA Expert Opin Biol Ther; 2019 Jul; 19(7):655-670. PubMed ID: 31056978 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy of lysosomal storage disorders. Salvetti A; Heard JM; Danos O Br Med Bull; 1995 Jan; 51(1):106-22. PubMed ID: 7767637 [TBL] [Abstract][Full Text] [Related]
14. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem. Macauley SL Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211 [TBL] [Abstract][Full Text] [Related]
15. Evolving therapies in neuronopathic LSDs: opportunities and challenges. Rajan DS; Escolar ML Metab Brain Dis; 2022 Oct; 37(7):2245-2256. PubMed ID: 35442005 [TBL] [Abstract][Full Text] [Related]
16. [Application of adeno-associated virus-mediated gene therapy in lysosomal storage diseases]. Lin XQ; Wang XL; Peng J Zhongguo Dang Dai Er Ke Za Zhi; 2022 Nov; 24(11):1281-1287. PubMed ID: 36398557 [TBL] [Abstract][Full Text] [Related]
17. Gene therapy for lysosomal storage disorders: a good start. Biffi A Hum Mol Genet; 2016 Apr; 25(R1):R65-75. PubMed ID: 26604151 [TBL] [Abstract][Full Text] [Related]
18. Lysosomal storage diseases: current therapies and future alternatives. Leal AF; Espejo-Mojica AJ; Sánchez OF; Ramírez CM; Reyes LH; Cruz JC; Alméciga-Díaz CJ J Mol Med (Berl); 2020 Jul; 98(7):931-946. PubMed ID: 32529345 [TBL] [Abstract][Full Text] [Related]